Recent evidence on delamanid use for rifampicin-resistant tuberculosis

J Thorac Dis. 2019 Mar;11(Suppl 3):S457-S460. doi: 10.21037/jtd.2018.11.26.

Authors

Emanuele Pontali¹, Rosella Centis², Lia D'Ambrosio³, Federica Toscanini⁴, Giovanni Battista Migliori²

Affiliations

¹ Department of Infectious Diseases, Galliera Hospital, Genoa, Italy.
² Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
³ Public Health Consulting Group, Lugano, Switzerland.
⁴ Department of Infectious Diseases, IRCCS AOU San Martino-IST, Genoa, Italy.

No abstract available

Publication types

Editorial
Comment